Todd Vorpahl

4.2k run for Sabrina Amanda and Hannah

Fundraising for Charcot-Marie-Tooth Association
US$4,750
raised of US$10,000 target
A reason to run
Spring
As a Charcot-Marie-Tooth community member your occasion, actions and life events can help the CMTA reach a world without CMT! Create a fundraising page and spread the word. Need help or more information? Contact Mary at mary@cmtausa.org.

Story

After they were born, we discovered each of our children had a 25% chance of inheriting a degenerative genetic neuromuscular disease affecting the peripheral nervous system. As a result, three of our six children have been diagnosed with CMT 4C, a condition inherited from a recessive gene from both parents. They already experience or will face a long list of progressive problems, including high arches, hammertoes, claw-like hands, spinal abnormalities, cataracts, deafness, high or flat arches, respiratory problems due to the progression of the disease and diaphragm weakness, bony or joint abnormalities, and central nervous system involvement (issues with cognition or other brain functions). This means spinal rod insertion surgery (our oldest has already had this), increased nerve and muscle pain, loss of peripheral limb function, and more.

Despite this, they maintain a very positive attitude, faith, and hope in life, no matter what their outcome. They are my heroes.

https://www.cmtausa.org/understa.../types-of-cmt/cmt-type-4/

The good news:

A gene replacement therapy has now found proof of concept as a result of statistically significant improvement in each mouse model behavioral analysis (i.e. motor performance in rotarod and foot grip measuring muscle strength, motor nerve conduction velocities, myelination in lumbar roots and sciatic nerves, etc.)

Clinical trial phase planning is now being led here in the United States by Steven Gray, PhD, University of Texas Southwestern Medical Center following this overseas successful research by Kleopas A. Kleopa, Senior Consultant Neurologist, head of Neuroscience Department, the Cyprus Institute of Neurology and Genetics, Cyprus.

https://www.cell.com/.../fulltext/S1525-0016(23)00452-5

https://www.researchgate.net/.../331995656_Gene...

Our primary barrier now is funding.

A “foresee” project sponsored in partnership with the CMTA will help us clear our funding hurdle, but like anything else requires intense patient advocacy. We have connected with 4C patients worldwide supporting fundraising efforts like this one of mine.

About the campaign

As a Charcot-Marie-Tooth community member your occasion, actions and life events can help the CMTA reach a world without CMT! Create a fundraising page and spread the word. Need help or more information? Contact Mary at mary@cmtausa.org.

About the charity

Our mission … to support the development of new drugs to treat CMT, to improve the quality of life for people with CMT, and, ultimately, to find a cure. Our vision … a world without CMT.

Donation summary

Total raised
US$4,750.00
Online donations
US$4,750.00
Offline donations
US$0.00

* Charities pay a small fee for our service. Find out how much it is and what we do for it.

This page has been created by a user of this platform to solicit donations to a charitable organization which has not provided consent or permission for this solicitation and has not reviewed or approved the content generated by this user. Donations may be used by a recipient charitable organization on an unrestricted basis, regardless of any commitment made by this user or any designations or restrictions made by you when making the donation.